| 投资者关系活动 | □特定对象调研 分析师会议 □ | | --- | --- | | 类别 | □ 媒体采访 √ 业绩说明会 | | | □ 新闻发布会 □ 路演活动 | | | □ 现场参观 | | | □ 其他 （请文字说明其他活动内容） | | 参与单位名称及 | 投资者网上提问 | | 人员姓名 | | | 时间 | 年 月 日 2025 5 14 (周三) 下午 14:00~17:00 | | 地点 | 公司通过全景网"投资者关系互动平台"（https://ir.p5w.net） | | | 采用网络远程的方式召开业绩说明会 | | 上市公司接待人 | 1、董事长陈融洁 | | 员姓名 | 2、董事、总经理朱小梅 | | | 3、董事、副总经理、财务负责人林琛 | | | 4、董事、副总经理、董事会秘书许海峰 | | | 5、独立董事刘琨 投资者提出的问题及公司回复情况 | | | 公司就投资者在本次说明会中提出的问题进行了回复： 1、公司是否有专业研发团队，学历分布都没有高学历人才 | | | 呢 | | 投资者关系活动 | 您好，公司非常重视研发及创新能力的建设，公司通过内部 | | 主要 ...

Core Viewpoint - Jiangsu Farsen Co., Ltd. reported a significant decline in revenue and net profit for 2024, with a focus on improving operational performance through new product development and expansion into new business areas [2][3]. Financial Performance - In 2024, the company achieved an operating income of 312 million yuan, a decrease of 29.97% year-on-year - The net profit attributable to shareholders was -106 million yuan, marking a shift from profit to loss - Revenue from the metal products business and environmental business was 225 million yuan and 87.59 million yuan, respectively, representing declines of 10.74% and 54.90% year-on-year [2]. Business Development Strategies - The company aims to enhance its metal products segment by researching and developing high-margin new products - In the environmental sector, the company is exploring new avenues such as coal mine high-salinity water treatment - The subsidiary, Dalian Guantaiyuan Environmental Technology Co., Ltd., is expanding into construction waste classification and large-item waste treatment projects [3]. Operational Updates - The coal mine high-salinity water treatment project is expected to stabilize water output by May 2025, which will alleviate operational pressure on Guantaiyuan [3]. - The company is focusing on pricing strategies, raw material price fluctuation responses, and competitive advantages in its metal products business [4]. Competitive Positioning - The company is enhancing product value and lifespan by developing special high-strength steel wires - Long-term agreements with suppliers are being established to mitigate risks associated with raw material price fluctuations [4]. Industry Insights - Experts suggest that manufacturing companies can enhance market competitiveness through technological research and digital transformation - There is potential for Farsen to integrate its products into downstream processes and collaborate with industry chain enterprises to create comprehensive environmental treatment solutions [5].

Group 1: Talent Development and Management - The company emphasizes continuous innovation in recruitment and talent management to align with strategic goals [2][3] - Plans to enhance employee training through the establishment of a dedicated training institution and collaboration with external consulting firms [3] Group 2: Shareholder Returns - For 2024, the company plans to distribute cash dividends of RMB 3 per 10 shares, totaling RMB 30.84 million [4] - Additionally, the company will increase its share capital by 3 shares for every 10 shares held, resulting in an increase of 3,084,000 shares [4] Group 3: Future Development Plans - The company aims to deepen its focus on fine chemicals, particularly in the pharmaceutical sector, while pursuing technological research and industrial exploration [5] - It seeks to become a trusted leader in the industry by aligning with the new development pattern of domestic and international dual circulation [5] Group 4: Market and Product Development - The company is committed to high-end and fine development strategies in the iodide product sector, enhancing R&D investment and market expansion [8] - It aims to optimize market layout and improve brand influence to achieve high-quality growth in iodide products [8] Group 5: Financial Performance - In 2024, the company achieved a revenue of RMB 132.79 million, representing a year-on-year growth of 29.53% [11] - The net profit attributable to shareholders was RMB 21.31 million, reflecting a year-on-year increase of 17.04% [11]

华安证券（600909）股份有限公司张志邦近期对湖南裕能（301358）进行研究并发布了研究报告《Q4业 绩筑底，涨价落地驱动盈利拐点显现》，给予湖南裕能买入评级。 湖南裕能 主要观点： 事件：公司发布2024年年报及一季报，碳酸锂价格下跌导致业绩承压2024年营收226亿元，同比-45.4%， 主因碳酸锂价格下跌传导至正极材料售价下降加之产能未出清。归母净利润5.94亿元，同比-62.45%，扣 非净利润5.70亿元，同比-62.44%。经营性净现金流-10.4亿元，主要系存货备货增加。Q4营收67.2亿元环 比+32%，归母净利1.03亿元。2025年Q1实现营业收入67.62亿元，同比+49.6%，主要得益于磷酸盐正极材 料销量增长63.68%至22.26万吨。归母净利润同比下滑40.56%至0.94亿元，主因营业成本增长52.82%至 63.89亿元，部分原材料价格上涨叠加销售规模扩大导致成本压力加剧。 磷酸铁锂出货量稳步增加，高端系列进展迅速 最新盈利预测明细如下： | 报告日期 | 机构简称 | 研究员 | 沂三年业绩 | 研报数 覆盖时长 | | 2025预测 | 2026预测 | 2027预测 ...

Core Viewpoint - The article emphasizes the importance of integrity and quality in business operations, highlighting the shared values between Wei Jianjun and Yu Donglai, particularly in opposing price wars and focusing on long-term development rather than short-term gains [2][3]. Group 1: Support for Yu Donglai and Integrity in Business - Wei Jianjun publicly supported Yu Donglai and his company, Pang Donglai, advocating for a business model based on honesty and transparency [2][3]. - Pang Donglai faced criticism from a blogger regarding the quality of their jade products, leading to a public defense and legal action from the company [1][3]. - The sales data from Pang Donglai indicated a total of 4,177 jade items sold from January to April, generating nearly 30 million yuan with an average gross margin of no more than 20% [1]. Group 2: Long-term Strategy and Quality Focus - Wei Jianjun's approach to business emphasizes quality over blind expansion, aligning with Yu Donglai's philosophy of maintaining integrity in operations [4][6]. - Long-term investments in research and development have allowed Great Wall Motors to maintain a strong position in the market without succumbing to competitive pressures [5][6]. - The company has consistently focused on specific market segments, such as SUVs, which has led to significant sales success, exemplified by the Haval H6 model [5]. Group 3: Corporate Culture and Leadership - Great Wall Motors fosters a culture of transparency and accountability, with regular self-reflection meetings to address issues and improve operations [9]. - Wei Jianjun's leadership style is characterized by a hands-on approach, actively engaging in key projects and maintaining close communication with teams [7][8]. - The company has a clear stance against unethical practices, emphasizing the importance of maintaining order and rules within the industry [8][9].

3.高管您好，能否请您介绍一下本期行业整体和行业内其 他主要企业的业绩表现？谢谢。 | | □特定对象调研 □分析师会议 | | --- | --- | | 投资者关系活 | □媒体采访 √业绩说明会 | | 动类别 | □新闻发布会 □路演活动 | | | □现场参观 □电话会议 | | | （请文字说明其他活动内容） □其他： | | 参与单位名称 | 瑜欣电子2024年度业绩说明会采用网络远程方式进行，面向全 | | 及人员姓名 | 体投资者 | | 时间 | 2025 年 5 月 9 日 15:00-17:00 | | 地点 | 深圳证券交易所"互动易平台"http://irm.cninfo.com.cn"云访谈" | | | 栏目 | | 公司接待人员 | 董事长：胡云平先生 | | 姓名 | 董事会秘书、财务总监：樊地先生 | | | 独立董事：罗楠女士 | | | 1.高管您好。请问贵公司本期财务报告中，盈利表现如何？ | | | 谢谢。 | | 投资者关系活 | 答：2024 年报告期内，公司实现营业总收入为 548,819,60 | | 动主要内容介 | 元，较上年同期增长 1.59 7.8 ...

Core Viewpoint - The company reported strong revenue and profit growth for 2024 and Q1 2025, indicating a robust financial performance and ongoing capacity expansion efforts [1][2]. Financial Performance - In 2024, the company achieved revenue of 1.86 billion, a year-on-year increase of 49.7%, and a net profit attributable to shareholders of 230 million, up 38.0% year-on-year [1]. - For Q1 2025, the company reported revenue of 450 million, a year-on-year increase of 47.4%, but a quarter-on-quarter decrease of 28.2%. The net profit attributable to shareholders was 60 million, reflecting a year-on-year increase of 57.4% and a quarter-on-quarter decrease of 12.5% [1][2]. - The gross margin for 2024 was 25.7%, down 1.7 percentage points year-on-year, while the net profit margin was 12.2%, down 1.0 percentage points year-on-year [2]. Cost Management - The company maintained stable expense ratios in 2024, with sales, management, R&D, and financial expense ratios at 3.2%, 2.6%, 4.8%, and -0.2% respectively [2]. - In Q1 2025, the expense ratios were 2.7%, 2.7%, 5.1%, and 0.0%, showing a year-on-year decrease in sales and management expenses [2]. Capacity Expansion - The company is actively expanding its production capacity, with investments of 160 million in projects for producing 9 million new energy vehicle stabilizers and 100,000 sets of robot and engineering machinery springs, expected to be operational by the end of 2025 [3]. - Additional investments of 250 million in high-performance springs and intelligent production lines are projected to yield benefits of 30 million in 2024, with completion expected by the end of 2026 [3]. Technological Development - The company invested 90 million in R&D in 2024, a year-on-year increase of 45.4%, and holds 20 national invention patents and 179 utility model patents [4]. - The company has developed advanced production processes for spring steel wire, meeting the technical demands of major automotive manufacturers [4]. Client Relationships - The company's products are integrated into the supply chains of major automotive manufacturers such as BYD, Geely, Great Wall, and Changan, as well as international suppliers like ZF, Hande, Knorr, and Bendix, establishing a strong market presence [4]. Profit Forecast - The company forecasts net profits attributable to shareholders of 290 million, 360 million, and 440 million for 2025, 2026, and 2027, respectively, with corresponding price-to-earnings ratios of 20x, 17x, and 13x [4].

Core Viewpoint - Kaisheng Technology (600552.SH) reported a significant increase in revenue and net profit for Q1 2025, driven by reduced losses in traditional display materials and successful market acceptance of new products [1] Group 1: Financial Performance - The company achieved a revenue of 1.265 billion yuan in Q1 2025 [1] - The net profit attributable to shareholders reached 23.8475 million yuan, marking a year-on-year increase of 73.01% [1] Group 2: Business Segments - Kaisheng Technology operates primarily in two segments: display materials and application materials [1] - In the display materials sector, the company has established a comprehensive industrial chain from glass substrates to integrated modules, enhancing cost control and quality consistency [1] Group 3: Application Materials - The application materials business focuses on zirconium, silicon, and titanium, transitioning from traditional ceramics to high-value electronic applications such as semiconductors and biomedical materials [2] - The company has developed a "large industry" platform for new materials, leveraging its leading position in the electric melting zirconia industry [2] Group 4: Innovation and R&D - Innovation is a core driver for the company's growth, with significant investments in R&D through national-level innovation platforms [2] - Kaisheng Technology has obtained a total of 582 authorized patents, including 167 invention patents [2] Group 5: Market Presence and Talent - The company has established a strong marketing network serving both domestic and international clients, including major brands like Amazon and Samsung [3] - Kaisheng Technology boasts a robust R&D team of 724 members and has received national recognition for its engineering teams [3] Group 6: Future Outlook - For 2025, the company aims to enhance operational quality and integrate technology with industry innovation, focusing on high-value product expansion in electronic information and semiconductor markets [3]

Group 1: Financial Performance - In 2024, the company's revenue reached 2.213 billion CNY, representing a year-on-year growth of 16.26% [3] - The net profit attributable to shareholders was 76.69 million CNY, a decline of 40.45% compared to the previous year [3] - In Q1 2025, revenue was 679 million CNY, showing a significant year-on-year increase of 66.60% [3] Group 2: Research and Development - The R&D investment for 2024 was 197.76 million CNY, an increase of 12.33% from 2023, accounting for 8.94% of total revenue [2] - In Q1 2025, R&D expenses were 55.99 million CNY, which is 8.24% of revenue [2] - The company achieved 20 utility model patents and has 8 invention patents under review in 2024 [2] Group 3: Cost Management and Strategy - The decline in net profit is attributed to increased R&D and management expenses due to product line expansion and sales promotion efforts [3] - The company is implementing cost reduction and efficiency enhancement plans, optimizing raw material inventory management, and maintaining stable relationships with suppliers [3] - The company aims to improve net profit margins by scaling up emerging product lines and achieving vertical integration [4] Group 4: Market Expansion and Future Outlook - The company is focusing on expanding product lines, including gaming power supplies, smart security, and energy storage systems, to achieve scale and profitability [4] - The establishment of a factory in Vietnam has helped mitigate risks associated with U.S. tariffs on exports [3] - Future growth drivers include technological advancements leading to higher speed, power, and intelligence in products [4]

Core Insights - Yongshun Bio achieved operating revenue of 269 million yuan and net profit of 40 million yuan in 2024, maintaining a steady operational trend [1] - The company has successfully expanded its overseas revenue, surpassing 20 million yuan for the first time [1] - In Q1 2025, Yongshun Bio reported operating revenue of 65.46 million yuan and net profit attributable to shareholders of 7.92 million yuan, continuing its stable performance [1] Product and Market Position - Yongshun Bio is a leading domestic veterinary biological product company, focusing on swine and poultry vaccines with over 30 product varieties [2] - The company holds a strong market position in core products, with significant market shares in swine vaccines, particularly the classical swine fever live vaccine and the three-in-one vaccine for swine [2] - Key products such as the pseudorabies live vaccine and the porcine circovirus type 2 inactivated vaccine saw substantial sales growth, with revenues of 14.91 million yuan (up 35.47%) and 8.12 million yuan (up 71.71%) respectively in 2024 [2] Financial and Operational Efficiency - Yongshun Bio has optimized its financial structure, reducing total liabilities by 16.35% compared to the beginning of the year, enhancing its balance sheet [2] - The company invested 23 million yuan in R&D in 2024, accounting for 8.54% of its operating revenue, and obtained new drug registration certificates and patents, enriching its product line [3] - The production system has undergone technological innovation and management upgrades, with successful GMP dynamic acceptance of its bacterial inactivated vaccine production line [3] International Expansion - Yongshun Bio has successfully registered new products in Egypt, adding to its international presence alongside Vietnam, with a total of 7 and 2 products registered in these countries respectively [4] - The company’s overseas revenue reached over 20 million yuan in 2024, marking a year-on-year growth of 34.31%, indicating an increasing contribution from international markets [4]